---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-024334"
form_type: "8-K"
ticker: "PIII"
cik: "0001832511"
company_name: "P3 Health Partners Inc."
filed_at: "2024-05-20T23:59:59+00:00"
generated_at: "2026-06-01T13:14:55.379092+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# P3 Health Partners receives Nasdaq bid price deficiency notice; 180-day cure period ends Nov 11, 2024

## Summary
- Received Nasdaq letter on May 15, 2024 for common stock (PIII) bid price below $1.00 for 31 straight business days.
- Must close at $1.00 or higher for at least 10 consecutive business days by November 11, 2024 to regain compliance.
- If not compliant by Nov 11, may qualify for an additional 180-day period if other listing standards are met.
- Stock remains listed for now; company will evaluate available options to cure the deficiency.

## SEC filing metadata
- accession: 0001628280-24-024334
- form_type: 8-K
- ticker: PIII
- cik: 0001832511
- company_name: P3 Health Partners Inc.
- filed_at: 2024-05-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832511/000162828024024334/0001628280-24-024334-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832511/000162828024024334/piii-20240515.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-024334
- JSON: https://secwatch.observer/filing/0001628280-24-024334.json
- Plain text: https://secwatch.observer/filing/0001628280-24-024334.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.